Labcorp to buy Opko unit's cancer test assets for up to $225M [Yahoo! Finance]
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
Dive Brief: Labcorp will pay up to $225 million to acquire the oncology diagnostics businesses of BioReference Health, a subsidiary of Opko Health, to expand its portfolio of tests used in cancer care. The deal, announced Tuesday, includes $192.5 million to be paid at closing and a payment of up to $32.5 million based on performance. The assets, including certain customer accounts, generate about $85 million to $100 million in annual revenue, according to the announcement. Labcorp expects the acquisition to be accretive to earnings in the first year after closing. Dive Insight: Labcorp has identified oncology as one of the high-growth testing areas where it wants to increase its laboratory service offerings. The others are women's health, neurology a
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses [Yahoo! Finance]Yahoo! Finance
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesPR Newswire
- Should Labcorp Stock Stay in Your Portfolio Right Now? [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Avoid LH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- HealthTrackRx CEO Martin Price Appointed to ACLA Board of Directors for 2025-2027 Term [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 2/6/25 - Beat
LH
Sec Filings
- 3/7/25 - Form 4
- 3/5/25 - Form 144
- 3/4/25 - Form 4
- LH's page on the SEC website